| Cancer-associated adipocytes: key players in breast cancer progression Q Wu, B Li, Z Li, J Li, S Sun, S Sun Journal of hematology & oncology 12, 1-15, 2019 | 392 | 2019 |
| Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study Q Wu, J Li, S Zhu, J Wu, C Chen, Q Liu, W Wei, Y Zhang, S Sun Oncotarget 8 (17), 27990, 2017 | 385 | 2017 |
| Chalcone Derivatives: Role in Anticancer Therapy Q Ouyang, Yang Li, Juanjuan Chen, Xinyue Fu, Xiaoyu Sun, Si Wu Biomolecules 11 (6), 894, 2021 | 242 | 2021 |
| Exosomes from the tumour-adipocyte interplay stimulate beige/brown differentiation and reprogram metabolism in stromal adipocytes to promote tumour progression Q Wu, J Li, Z Li, S Sun, S Zhu, L Wang, J Wu, J Yuan, Y Zhang, S Sun, ... Journal of Experimental & Clinical Cancer Research 38, 1-20, 2019 | 152 | 2019 |
| S‐adenosylmethionine: a metabolite critical to the regulation of autophagy Y Ouyang, Q Wu, J Li, S Sun, S Sun Cell proliferation 53 (11), e12891, 2020 | 139 | 2020 |
| Emerging phagocytosis checkpoints in cancer immunotherapy PW Yu'e Liu, Yanjin Wang, Yanrong Yang, Linjun Weng, Qi Wu, Jin Zhang ... Signal Transduction and Targeted Therapy 8 (1), 104, 2023 | 136 | 2023 |
| Dietary regulation in health and disease Q Wu, ZJ Gao, X Yu, P Wang Signal Transduction and Targeted Therapy 7 (1), 252, 2022 | 108 | 2022 |
| Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression Q Wu, S Sun, Z Li, Q Yang, B Li, S Zhu, L Wang, J Wu, J Yuan, C Yang, ... Molecular cancer 17, 1-7, 2018 | 103 | 2018 |
| Trial Watch: experimental TLR7/TLR8 agonists for oncological indications G Frega, Q Wu, J Le Naour, E Vacchelli, L Galluzzi, G Kroemer, O Kepp Oncoimmunology 9 (1), 1796002, 2020 | 90 | 2020 |
| Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression Z Liu, Z Gao, B Li, J Li, Y Ou, X Yu, Z Zhang, S Liu, X Fu, H Jin, J Wu, ... Oncoimmunology 11 (1), 2085432, 2022 | 88 | 2022 |
| Cancer-associated adipocytes as immunomodulators in cancer Q Wu, B Li, J Li, S Sun, J Yuan, S Sun Biomarker Research 9, 1-21, 2021 | 75 | 2021 |
| RETRACTED ARTICLE: Breast cancer-released exosomes trigger cancer-associated cachexia to promote tumor progression Q Wu, S Sun, Z Li, Q Yang, B Li, S Zhu, L Wang, J Wu, J Yuan, C Wang, ... Adipocyte 8 (1), 31-45, 2019 | 70 | 2019 |
| IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms GK Qi Wu, Ai-Ling Tian, Bei Li, Marion Leduc, Sabrina Forveille, Peter ... Journal for ImmunoTherapy of Cancer 9 (6), e002722, 2021 | 63 | 2021 |
| Centrosome dysfunction: a link between senescence and tumor immunity Q Wu, B Li, L Liu, S Sun, S Sun Signal Transduction and Targeted Therapy 5 (1), 107, 2020 | 63 | 2020 |
| Outcomes of patients with inflammatory breast cancer by hormone receptor-and HER2-defined molecular subtypes: A population-based study from the SEER program J Li, Y Xia, Q Wu, S Zhu, C Chen, W Yang, W Wei, S Sun Oncotarget 8 (30), 49370, 2017 | 49 | 2017 |
| Single-cell and spatially resolved analysis uncovers cell heterogeneity of breast cancer SQ Liu, ZJ Gao, J Wu, HM Zheng, B Li, S Sun, XY Meng, Q Wu Journal of Hematology & Oncology 15 (1), 19, 2022 | 48 | 2022 |
| DNER promotes epithelial–mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer Z Wang, Z Li, Q Wu, C Li, J Li, Y Zhang, C Wang, S Sun, S Sun Cell death & disease 11 (8), 642, 2020 | 48 | 2020 |
| Serine and metabolism regulation: a novel mechanism in antitumor immunity and senescence Q Wu, X Chen, J Li, S Sun Aging and disease 11 (6), 1640, 2020 | 45 | 2020 |
| Extracellular vesicles and immunogenic stress in cancer Q Wu, H Zhang, S Sun, L Wang, S Sun Cell Death & Disease 12 (10), 894, 2021 | 43 | 2021 |
| Monocarboxylate transporters in breast cancer and adipose tissue are novel biomarkers and potential therapeutic targets Z Li, Q Wu, S Sun, J Wu, J Li, Y Zhang, C Wang, J Yuan, S Sun Biochemical and biophysical research communications 501 (4), 962-967, 2018 | 39 | 2018 |
Oliver KeppINSERM UMR1138 / Gustave Roussy Cancer CenterE-mailová adresa ověřena na: gustaveroussy.fr
